S Trancă1, J T Oever2, C Ciuce3, M Netea2, A Slavcovici4, C Petrișor5, N Hagău5. 1. Department of Anaesthesia and Intensive Care II, Clinical Emergency County Hospital of Cluj, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 400006 Clinicilor 3-5, Cluj-Napoca, Romania. sebi_tranca@yahoo.com. 2. Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. 3. Surgical Department I, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania. 4. Department of Infectious Diseases, "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania. 5. Department of Anaesthesia and Intensive Care II, Clinical Emergency County Hospital of Cluj, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 400006 Clinicilor 3-5, Cluj-Napoca, Romania.
Abstract
BACKGROUND: To investigate whether sTREM-1, sIL-2Rα, sCD163, and IL-6 predict septic complications following polytrauma. Prospective observational study in a university hospital intensive care unit. METHODS: Blood samples were drawn on admission, 24 and 48 h after the injury from 64 adult polytrauma patients. The occurence of infectious complications was investigated. The sepsis-free rates for the multiple trauma patients were considered as end points in the Kaplan-Meier plot analysis. RESULTS: Upon admission, sIL-2Rα mean values were higher in the T group compared to the T&S patients (1789 ± 1027 pg/mL versus 1280 ± 605 pg/mL, p = 0.02). The initial mean values of sTREM-1, IL-6, and sCD163 did not discriminate between the T and T&S groups patients (p > 0.05). sTREM-1 cutoff was 62 pg/mL: the sepsis-free rates differed significantly between the patients with sTREM-1 concentrations lower and higher than the cutoff (80 versus 48 %, p < 0.01). From the patients with serum sIL-2Rα ≥1593 pg/mL, 86 % did not present sepsis; for sIL-2Rα values in the range 946-1593 pg/mL, the sepsis-free rate was 68 %, while from the patients with sIL-2Rα <945 pg/mL, only 40 % remained sepsis-free (p = 0.05). sCD163 cutoff of 1000 ng/mL did not discriminate between the patients (76 versus 64 %, p = 0.28). For IL-6, the sepsis-free rates differed significantly between the patients with concentrations lower and higher than 400 pg/mL (78 versus 38 %, p < 0.01). CONCLUSIONS: sTREM-1, sIL-2Rα, and IL-6, but not CD163, may be used as prognostic markers for the occurrence of sepsis in multiple trauma patients. LEVEL OF EVIDENCE: Level II-Diagnostic tests and criteria.
BACKGROUND: To investigate whether sTREM-1, sIL-2Rα, sCD163, and IL-6 predict septic complications following polytrauma. Prospective observational study in a university hospital intensive care unit. METHODS: Blood samples were drawn on admission, 24 and 48 h after the injury from 64 adult polytraumapatients. The occurence of infectious complications was investigated. The sepsis-free rates for the multiple traumapatients were considered as end points in the Kaplan-Meier plot analysis. RESULTS: Upon admission, sIL-2Rα mean values were higher in the T group compared to the T&S patients (1789 ± 1027 pg/mL versus 1280 ± 605 pg/mL, p = 0.02). The initial mean values of sTREM-1, IL-6, and sCD163 did not discriminate between the T and T&S groups patients (p > 0.05). sTREM-1 cutoff was 62 pg/mL: the sepsis-free rates differed significantly between the patients with sTREM-1 concentrations lower and higher than the cutoff (80 versus 48 %, p < 0.01). From the patients with serum sIL-2Rα ≥1593 pg/mL, 86 % did not present sepsis; for sIL-2Rα values in the range 946-1593 pg/mL, the sepsis-free rate was 68 %, while from the patients with sIL-2Rα <945 pg/mL, only 40 % remained sepsis-free (p = 0.05). sCD163 cutoff of 1000 ng/mL did not discriminate between the patients (76 versus 64 %, p = 0.28). For IL-6, the sepsis-free rates differed significantly between the patients with concentrations lower and higher than 400 pg/mL (78 versus 38 %, p < 0.01). CONCLUSIONS: sTREM-1, sIL-2Rα, and IL-6, but not CD163, may be used as prognostic markers for the occurrence of sepsis in multiple traumapatients. LEVEL OF EVIDENCE: Level II-Diagnostic tests and criteria.
Authors: Jaime Latour-Pérez; Adoración Alcalá-López; Miguel-Angel García-García; José F Sánchez-Hernández; Carmen Abad-Terrado; José A Viedma-Contreras; Mar Masiá; Matilde González-Tejera; David Arizo-León; María-Jesús Broch Porcar; Fernando Bonilla-Rovira; Félix Gutiérrez Journal: Clin Biochem Date: 2010-03-17 Impact factor: 3.281
Authors: R Phillip Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven A Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno Journal: Crit Care Med Date: 2013-02 Impact factor: 7.598
Authors: Anders G Kjærgaard; Sidsel Rødgaard-Hansen; Anders Dige; Jan Krog; Holger J Møller; Else Tønnesen Journal: PLoS One Date: 2014-03-17 Impact factor: 3.240
Authors: Jan Budczies; Frederick Klauschen; Bruno V Sinn; Balázs Győrffy; Wolfgang D Schmitt; Silvia Darb-Esfahani; Carsten Denkert Journal: PLoS One Date: 2012-12-14 Impact factor: 3.240